Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...
Global, randomized Phase 2 study to evaluate the addition of givastomig, a CLDN18.2 x 4-1BB bispecific antibody (8 mg/kg and 12 mg/kg) to standard of care immunochemotherapy in patients with first ...
Hosted on MSN
Large Swedish study finds COVID-19 vaccination unrelated to fertility or childbirth rates
Large real-world Swedish data provide reassurance that COVID-19 vaccination does not reduce childbirth rates, helping counter persistent misinformation about fertility risks. Study: COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results